# Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

> **NCT07549022** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Ankit Mangla, MD** · enrollment: 17 (estimated)

## Conditions studied

- Malignant Peripheral Nerve Sheath Tumors
- MPNST

## Interventions

- **DRUG:** BMS-986504

## Key facts

- **NCT ID:** NCT07549022
- **Lead sponsor:** Ankit Mangla, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2028-07
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07549022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07549022, "Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07549022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*